CAPSL Fundamental Analysis - CAPSOL TECHNOLOGIES ASA

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to CAPSL. CAPSL was compared to 113 industry peers in the Machinery industry. CAPSL may be in some trouble as it scores bad on both profitability and health. CAPSL shows excellent growth, but is valued quite expensive already.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CAPSL has reported negative net income.

In the past year CAPSL has reported a negative cash flow from operations.

CAPSL had negative earnings in each of the past 5 years.

In the past 5 years CAPSL always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -27.53%, CAPSL is not doing good in the industry: 91.15% of the companies in the same industry are doing better.

The Return On Equity of CAPSL (-50.66%) is worse than 86.73% of its industry peers.

		Industry Rank	Sector Rank
ROA	-27.53%
ROE	-50.66%
ROIC	N/A

ROA(3y)-26.45%

ROA(5y)-39.39%

ROE(3y)-68.07%

ROE(5y)-85.43%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 69.96%, CAPSL belongs to the best of the industry, outperforming 95.58% of the companies in the same industry.

The Profit Margin and Operating Margin are not available for CAPSL so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	69.96%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CAPSL does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for CAPSL has been increased compared to 1 year ago.

Compared to 5 years ago, CAPSL has more shares outstanding

The debt/assets ratio for CAPSL has been reduced compared to a year ago.

2.2 Solvency

A Debt/Equity ratio of 0.30 indicates that CAPSL is not too dependend on debt financing.

With a Debt to Equity ratio value of 0.30, CAPSL perfoms like the industry average, outperforming 53.98% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.3
Debt/FCF	N/A
Altman-Z	N/A

ROIC/WACCN/A

WACC8.22%

2.3 Liquidity

A Current Ratio of 1.33 indicates that CAPSL should not have too much problems paying its short term obligations.

Looking at the Current ratio, with a value of 1.33, CAPSL is doing worse than 62.83% of the companies in the same industry.

CAPSL has a Quick Ratio of 1.33. This is a normal value and indicates that CAPSL is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 1.33, CAPSL is in the better half of the industry, outperforming 73.45% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.33
Quick Ratio	1.33

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CAPSL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.19%.

CAPSL shows a strong growth in Revenue. In the last year, the Revenue has grown by 175.64%.

The Revenue has been growing by 278.38% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-5.19%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-127.27%

Revenue 1Y (TTM)175.64%

Revenue growth 3Y1253.2%

Revenue growth 5Y278.38%

Sales Q2Q%-11.06%

3.2 Future

Based on estimates for the next years, CAPSL will show a very strong growth in Earnings Per Share. The EPS will grow by 51.12% on average per year.

Based on estimates for the next years, CAPSL will show a very strong growth in Revenue. The Revenue will grow by 33.97% on average per year.

EPS Next Y-67.61%

EPS Next 2Y-18.51%

EPS Next 3Y51.12%

EPS Next 5YN/A

Revenue Next Year-16.41%

Revenue Next 2Y11.2%

Revenue Next 3Y33.97%

Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CAPSL. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CAPSL. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

CAPSL's earnings are expected to grow with 51.12% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-18.51%

EPS Next 3Y51.12%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CAPSL!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

CAPSOL TECHNOLOGIES ASA

OSL:CAPSL (12/19/2025, 4:10:38 PM)

5.9

-0.34 (-5.45%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryMachinery

Earnings (Last)11-11 2025-11-11/bmo

Earnings (Next)N/A N/A

Inst Owners12.27%

Inst Owner ChangeN/A

Ins Owners2.55%

Ins Owner ChangeN/A

Market Cap389.46M

Revenue(TTM)94.16M

Net Income(TTM)-40.95M

Analysts83.64

Price Target15.3 (159.32%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-89.02%

Min EPS beat(2)-163.52%

Max EPS beat(2)-14.51%

EPS beat(4)2

Avg EPS beat(4)-8.1%

Min EPS beat(4)-163.52%

Max EPS beat(4)142.72%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)1

Avg Revenue beat(2)-9.1%

Min Revenue beat(2)-30.84%

Max Revenue beat(2)12.64%

Revenue beat(4)2

Avg Revenue beat(4)-9.01%

Min Revenue beat(4)-30.84%

Max Revenue beat(4)12.64%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)-5.29%

EPS NY rev (3m)-23.45%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)-14.12%

Revenue NY rev (3m)-15.61%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	3.93
P/FCF	N/A
P/OCF	N/A
P/B	4.82
P/tB	5.7
EV/EBITDA	N/A

EPS(TTM)-0.81

EYN/A

EPS(NY)-0.77

Fwd EYN/A

FCF(TTM)-0.51

FCFYN/A

OCF(TTM)-0.26

OCFYN/A

SpS1.5

BVpS1.22

TBVpS1.03

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-27.53%
ROE	-50.66%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	69.96%
FCFM	N/A

ROA(3y)-26.45%

ROA(5y)-39.39%

ROE(3y)-68.07%

ROE(5y)-85.43%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0.67

Health

		Industry Rank	Sector Rank
Debt/Equity	0.3
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	84.1%
Cap/Sales	16.62%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.33
Quick Ratio	1.33
Altman-Z	N/A

F-Score3

WACC8.22%

ROIC/WACCN/A

Cap/Depr(3y)663.36%

Cap/Depr(5y)N/A

Cap/Sales(3y)130.85%

Cap/Sales(5y)1638.88%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-5.19%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-127.27%

EPS Next Y-67.61%

EPS Next 2Y-18.51%

EPS Next 3Y51.12%

EPS Next 5YN/A

Revenue 1Y (TTM)175.64%

Revenue growth 3Y1253.2%

Revenue growth 5Y278.38%

Sales Q2Q%-11.06%

Revenue Next Year-16.41%

Revenue Next 2Y11.2%

Revenue Next 3Y33.97%

Revenue Next 5YN/A

EBIT growth 1Y13.1%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-44.23%

EBIT Next 3Y43.92%

EBIT Next 5YN/A

FCF growth 1Y51.39%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y49.74%

OCF growth 3YN/A

OCF growth 5YN/A

CAPSOL TECHNOLOGIES ASA / CAPSL.OL FAQ

Can you provide the ChartMill fundamental rating for CAPSOL TECHNOLOGIES ASA?

ChartMill assigns a fundamental rating of 3 / 10 to CAPSL.OL.

What is the valuation status of CAPSOL TECHNOLOGIES ASA (CAPSL.OL) stock?

ChartMill assigns a valuation rating of 1 / 10 to CAPSOL TECHNOLOGIES ASA (CAPSL.OL). This can be considered as Overvalued.

Can you provide the profitability details for CAPSOL TECHNOLOGIES ASA?

CAPSOL TECHNOLOGIES ASA (CAPSL.OL) has a profitability rating of 1 / 10.

What is the financial health of CAPSOL TECHNOLOGIES ASA (CAPSL.OL) stock?

The financial health rating of CAPSOL TECHNOLOGIES ASA (CAPSL.OL) is 3 / 10.

CAPSOL TECHNOLOGIES ASA (CAPSL.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

CAPSOL TECHNOLOGIES ASA / CAPSL.OL FAQ

Can you provide the ChartMill fundamental rating for CAPSOL TECHNOLOGIES ASA?

What is the valuation status of CAPSOL TECHNOLOGIES ASA (CAPSL.OL) stock?

Can you provide the profitability details for CAPSOL TECHNOLOGIES ASA?

What is the financial health of CAPSOL TECHNOLOGIES ASA (CAPSL.OL) stock?